MCID: PRC016
MIFTS: 60

Pre-Eclampsia

Categories: Blood diseases, Cardiovascular diseases, Nephrological diseases, Rare diseases, Reproductive diseases, Respiratory diseases

Aliases & Classifications for Pre-Eclampsia

MalaCards integrated aliases for Pre-Eclampsia:

Name: Pre-Eclampsia 12 25 44 15 73
Preeclampsia 12 76 25 59 29 55 6
Pregnancy Associated Hypertension 12 73
Gestational Hypertension 12 15
Hypertension, Pregnancy-Induced, Susceptibility to 6
Proteinuric Hypertension of Pregnancy 12
Gestational Proteinuric Hypertension 25
Transient Hypertension of Pregnancy 73
Hypertension Induced by Pregnancy 12
Preeclampsia, Susceptibility to 6
Pregnancy-Induced Hypertension 25
Pre-Eclamptic Toxaemia 12
Preeclampsia/eclampsia 12
Toxaemia of Pregnancy 12
Toxemia of Pregnancy 25
Pregnancy Toxemias 55
Pregnancy Toxemia 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10591
MeSH 44 D011225
Orphanet 59 ORPHA275555
ICD10 via Orphanet 34 O14.2 O14.9 O14.0 more
UMLS via Orphanet 74 C0032914

Summaries for Pre-Eclampsia

Genetics Home Reference : 25 Preeclampsia is a complication of pregnancy in which affected women develop high blood pressure (hypertension); they can also have abnormally high levels of protein in their urine (proteinuria). This condition usually occurs in the last few months of pregnancy and often requires early delivery of the infant. However, this condition can also appear shortly after giving birth (postpartum preeclampsia).

MalaCards based summary : Pre-Eclampsia, also known as preeclampsia, is related to mild pre-eclampsia and eclampsia, and has symptoms including edema, hyperemesis gravidarum and morning sickness. An important gene associated with Pre-Eclampsia is NSD1 (Nuclear Receptor Binding SET Domain Protein 1), and among its related pathways/superpathways are Signaling events mediated by VEGFR1 and VEGFR2 and Glypican 1 network. The drugs Methyldopa and Calcium Carbonate have been mentioned in the context of this disorder. Affiliated tissues include placenta, endothelial and testes.

Disease Ontology : 12 A hypertension occurring during pregnancy characterized by large amounts of protein in the urine (proteinuria) and edema, usually by the last trimester of pregnancy.

Wikipedia : 76 Pre-eclampsia (PE) is a disorder of pregnancy characterized by the onset of high blood pressure and... more...

Related Diseases for Pre-Eclampsia

Diseases in the Eclampsia family:

Pre-Eclampsia Severe Pre-Eclampsia

Diseases related to Pre-Eclampsia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 359)
# Related Disease Score Top Affiliating Genes
1 mild pre-eclampsia 34.8 PGF FLT1
2 eclampsia 33.8 TAC3 STOX1 SERPINC1 PGF PEE1 FLT1
3 hellp syndrome 33.1 SERPINC1 PGF FLT1
4 preeclampsia/eclampsia 1 32.6 PEE1 NSD1
5 placental abruption 31.1 SERPINC1 PGF FLT1
6 microvascular complications of diabetes 5 30.4 PGF NOS3 FLT1
7 homocysteinemia 30.3 SERPINC1 NOS3 H19
8 coronary heart disease 1 30.1 WFDC21P NOS3 H19
9 arteries, anomalies of 30.0 SERPINC1 PGF NOS3 FLT1
10 placenta accreta 29.9 PGF FLT1
11 renal cell carcinoma, nonpapillary 29.7 TUG1 MALAT1 HOTAIR H19 FLT1
12 melanoma 29.6 WFDC21P SPRY4-IT1 MALAT1 HOTAIR H19
13 severe pre-eclampsia 13.0
14 preeclampsia/eclampsia 4 12.1
15 preeclampsia/eclampsia 5 12.1
16 preeclampsia/eclampsia 2 12.1
17 preeclampsia/eclampsia 3 12.1
18 gestational diabetes 11.7
19 hypoxia 10.5
20 polymorphic reticulosis 10.5
21 diabetes mellitus 10.4
22 familial hypertension 10.4
23 postpartum psychosis 10.4
24 epithelioid hemangioendothelioma 10.4 PGF FLT1
25 cancer-associated retinopathy 10.4 PGF FLT1
26 twin-to-twin transfusion syndrome 10.3 PGF FLT1
27 placental insufficiency 10.3
28 retinal vascular occlusion 10.3 SERPINC1 PGF
29 hypertension, essential 10.3
30 antiphospholipid syndrome 10.3
31 placenta praevia 10.3
32 neonatal jaundice 10.3
33 gastric cardia adenocarcinoma 10.2 HOTAIR H19
34 hydatidiform mole, recurrent, 1 10.2
35 body mass index quantitative trait locus 1 10.2
36 peripartum cardiomyopathy 10.2
37 patau syndrome 10.2
38 cortical blindness 10.2
39 thrombophilia 10.2
40 gestational trophoblastic neoplasm 10.2
41 kidney disease 10.2
42 atherosclerosis susceptibility 10.2 TUG1 NOS3 H19
43 breast cancer 10.2
44 retinal detachment 10.2
45 chronic kidney failure 10.2
46 chorioamnionitis 10.2
47 pulmonary edema 10.2
48 ischemia 10.2
49 placenta disease 10.2
50 triploidy 10.2

Graphical network of the top 20 diseases related to Pre-Eclampsia:



Diseases related to Pre-Eclampsia

Symptoms & Phenotypes for Pre-Eclampsia

UMLS symptoms related to Pre-Eclampsia:


edema, hyperemesis gravidarum, morning sickness

Drugs & Therapeutics for Pre-Eclampsia

Drugs for Pre-Eclampsia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 426)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methyldopa Approved Phase 4,Phase 2,Phase 1,Not Applicable 555-30-6 38853
2
Calcium Carbonate Approved, Investigational Phase 4,Phase 3,Not Applicable 471-34-1
3
Remifentanil Approved Phase 4,Phase 2,Phase 1 132875-61-7 60815
4
Amlodipine Approved Phase 4 88150-42-9 2162
5
Metformin Approved Phase 4,Phase 2,Phase 3,Not Applicable 657-24-9 14219 4091
6
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 50-78-2 2244
7
Bupivacaine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 2180-92-9, 38396-39-3 2474
8
Enoxaparin Approved Phase 4,Phase 3,Phase 2,Not Applicable 9005-49-6 772
9
Heparin Approved, Investigational Phase 4,Phase 2,Phase 3,Early Phase 1 9005-49-6 772 46507594
10
Dalteparin Approved Phase 4,Phase 2,Phase 3,Early Phase 1 9005-49-6
11
leucovorin Approved Phase 4,Phase 3,Phase 2,Not Applicable 58-05-9 6006 143
12
Oxytocin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 50-56-6 439302 53477758
13
Zinc Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 7440-66-6
14
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 90-82-4 7028
15
Phenylephrine Approved Phase 4,Not Applicable 59-42-7 6041
16
Oxymetazoline Approved, Investigational Phase 4,Not Applicable 1491-59-4 4636
17
Ephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 299-42-3 9294
18
Misoprostol Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 59122-46-2 5282381
19
Levobupivacaine Approved, Investigational Phase 4 27262-47-1 92253
20
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7487-88-9 24083
21
Furosemide Approved, Vet_approved Phase 4,Phase 2 54-31-9 3440
22
Clonidine Approved Phase 4,Phase 1,Phase 2,Not Applicable 4205-90-7 2803
23
Captopril Approved Phase 4 62571-86-2 44093
24
Ibuprofen Approved Phase 4,Phase 2,Phase 3,Not Applicable 15687-27-1 3672
25
Acetaminophen Approved Phase 4,Phase 2,Phase 3,Not Applicable 103-90-2 1983
26
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
27
Nifedipine Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 21829-25-4 4485
28
Labetalol Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 36894-69-6 3869
29
Benzocaine Approved, Investigational Phase 4,Phase 3,Not Applicable 94-09-7, 1994-09-7 2337
30 tannic acid Approved Phase 4,Phase 3,Not Applicable
31
Insulin Aspart Approved Phase 4,Phase 3,Not Applicable 116094-23-6 16132418
32
Insulin Lispro Approved Phase 4,Not Applicable 133107-64-9
33
Glyburide Approved Phase 4,Not Applicable 10238-21-8 3488
34
Azithromycin Approved Phase 4,Phase 3 83905-01-5 55185 447043
35
Warfarin Approved Phase 4 81-81-2 6691 54678486
36
Insulin Detemir Approved Phase 4,Phase 3,Not Applicable 169148-63-4 5311023
37
Desogestrel Approved Phase 4 54024-22-5 40973
38
Etonogestrel Approved, Investigational Phase 4 54048-10-1 6917715 40976
39
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 77-92-9 311
40
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 59-30-3 6037
41
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 1,Phase 2,Not Applicable 50-14-6 5280793
42
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 1406-16-2
43
Vitamin D3 Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 67-97-0 5280795 6221
44
Serine Approved, Nutraceutical Phase 4,Phase 3,Early Phase 1,Not Applicable 56-45-1 5951
45 Antihypertensive Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
46 Bone Density Conservation Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
47 Calcium, Dietary Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
48 Adrenergic Agonists Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
49 Adrenergic alpha-Agonists Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
50 Autonomic Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 747)
# Name Status NCT ID Phase Drugs
1 Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape) Unknown status NCT01361425 Phase 4 methildopa;placebo
2 Low Dose Calcium to Prevent Preeclampsia Unknown status NCT02338687 Phase 4
3 Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia Unknown status NCT00117546 Phase 4 alpha methyldopa
4 Remifentanil for General Anesthesia in Preeclamptics Unknown status NCT00567957 Phase 4 Remifentanil;Saline
5 Viagra for the Treatment of IUGR Unknown status NCT00347867 Phase 4 Viagra administration in IUGR/PET pregnancies
6 Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation Unknown status NCT02353806 Phase 4 Amlodipine besylate
7 Metformin and Gestational Diabetes in High-risk Patients: a RCTs Unknown status NCT00883259 Phase 4 Metformin
8 Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers Completed NCT01729468 Phase 4 Aspirin;Placebo
9 Adding MgSO4 to Epidural Levobupivacaine in CS for Patients With Preeclampsia Completed NCT02699827 Phase 4 Levobupivacaine hydrochloride;Magnesium sulphate;Saline 0.9%
10 Treatment Approaches to Preeclampsia Completed NCT01030627 Phase 4
11 Diuretics for Postpartum High Blood Pressure in Preeclampsia Completed NCT02163655 Phase 4 FUROSEMIDE;Placebo
12 Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia Completed NCT01352234 Phase 4 Acetylsalicylic Acid 160 mg;Acetylsalicylic Acid 80 mg
13 Effectiveness Study of Short Course of Magnesium Sulfate for Severe Preeclamsia Completed NCT01408979 Phase 4 Magnesium sulfate 12 hours;Magnesium sulfate 24 hours
14 Trial of Early Screening Test for Pre-eclampsia and Growth Restriction Completed NCT03674606 Phase 4 Low dose aspirin
15 A Trial Comparing Treatment With the Springfusor Infusion Pump to the IV Magnesium Sulfate Regimen Completed NCT02091401 Phase 4 Magnesium Sulfate
16 Clonidine Versus Captopril for Treatment of Postpartum Very High Blood Pressure Completed NCT01761916 Phase 4 CLONIDINE;CAPTOPRIL
17 The Effect of Ibuprofen on Post-partum Blood Pressure in Women With Hypertensive Disorders of Pregnancy Completed NCT02891174 Phase 4 Ibuprofen;Acetaminophen
18 Effects of Magnesium Sulphate on Sugammadex Reversal of Rocuronium Induced Blockade in Gynaecology Patients Completed NCT01972659 Phase 4 placebo;Magnesium Sulphate;sugammadex
19 Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy Completed NCT01912677 Phase 4 Nifedipine;Labetalol;Methyldopa
20 Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women Completed NCT03528967 Phase 4 Enoxaparin 40 mg / 0.4 mL Prefilled Syringe;Aspirin 100 mg Oral Tablet, Enteric Coated
21 Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies Completed NCT01608347 Phase 4 LMWH+Folic acid;Folic Acid
22 Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT Completed NCT00790062 Phase 4 Oxytocin
23 Timing of Initiation of LMWH Administration in Pregnant Women With APS Completed NCT02326051 Phase 4 Enoxaparin;Enoxaparin
24 Metformin Versus Insulin in Gestational Diabetes Completed NCT01240785 Phase 4 metformin;insulin
25 Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients Completed NCT02466204 Phase 4 corifollitropin alfa;Follitropin Beta
26 Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo Completed NCT00744965 Phase 4 Glyburide;Placebo
27 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women Completed NCT02377349 Phase 4 Saline placebo
28 Impact of Antichlamydial Treatment on the Rate of Preeclampsia Recruiting NCT03233880 Phase 4 Azithromycin 1gm
29 Efficacy and Safety of 1 g Vs 2 g Per Hour Intravenous Maintenance Dose of MgSO4 in Women With Severe Pre-eclampsia Recruiting NCT03164304 Phase 4 Magnesium Sulfate
30 Phenylephrine Versus Ephedrine in Pre-eclampsia Recruiting NCT02025426 Phase 4 Phenylephrine;Ephedrine
31 Early Vascular Adjustments During Hypertensive Pregnancy Recruiting NCT02531490 Phase 4 Labetalol;Nifedipine;Methyldopa
32 Oral Nifedipine Versus Labetalol in Treatment of Postpartum Hypertension Recruiting NCT03449277 Phase 4 Oral Tablet
33 Response to Anti-hypertensives in Pregnant and Postpartum Patients Recruiting NCT03506724 Phase 4 Nifedipine;Labetalol
34 Is Procardia XL 60 mg Q Daily Equivalent to 30 mg XL Given Twice Daily? Recruiting NCT03595982 Phase 4 Procardia XL 30Mg;Procardia XL 60Mg
35 Chronotherapy With Low-dose Aspirin for Primary Prevention Recruiting NCT00725127 Phase 4 aspirin;aspirin
36 A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy Recruiting NCT02920593 Phase 4 Vitamin D3
37 Chronic Hypertension and Pregnancy (CHAP) Project Recruiting NCT02299414 Phase 4 Anti-hypertensive therapy
38 Use of Warfarin After the First Trimester in Pregnant Women With APS Recruiting NCT02303171 Phase 4 Enoxaparin;Warfarin
39 Myo-Inositol- Based Co-treatment in Women With PCOS Undergoing Assisted Reproductive Technology Recruiting NCT03177122 Phase 4 Myo-inositol
40 Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Recruiting NCT03620890 Phase 4 Neutral Protamine Hagedorn (NPH);Detemir insulin
41 A Comparison of Oral Misoprostol and Vaginal Misoprostol for Cervical Ripening and Induction of Labor Recruiting NCT02777190 Phase 4 Misoprostol
42 Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features Active, not recruiting NCT02911701 Phase 4 Acetaminophen;Ibuprofen
43 Contraception in Women With Sickle Cell Disease Active, not recruiting NCT02594462 Phase 4 etonogestrel-releasing implant contraceptive
44 The Effect of Two Aspirin Dosing Strategies for Obese Women at High Risk for Preeclampsia Not yet recruiting NCT03735433 Phase 4 162mg aspirin dose
45 Discontinuation of Magnesium Sulfate After Delivery in Women With Severe Preeclampsia. A Randomized Controlled Trial Not yet recruiting NCT03318211 Phase 4 Magnesium Sulfate
46 Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus Not yet recruiting NCT03570632 Phase 4 Metformin
47 Effect of Administering Intravenous Magnesium Sulfate on Fetal Cardiotocography and Neonatal Outcome in Preeclamptic Patients Not yet recruiting NCT03237000 Phase 4 MgSO4
48 A Randomized Trial Comparing Oral Misoprostol Alone With Oral Misoprostol Followed by Oxytocin in Women Induced for Hypertension of Pregnancy Not yet recruiting NCT03749902 Phase 4 Oral misoprostol;Oxytocin
49 Metformin Use to Improve Pregnancy Outcome in Women With Type 1 Diabetes. Not yet recruiting NCT03765359 Phase 4 metforminhydrochloride;Placebo Oral Tablet
50 The Effectiveness and Safety of the Prolonged Down-regulation Protocol for Controlled Ovarian Hyperstimulation Not yet recruiting NCT03809221 Phase 4 Triptorelin acetate

Search NIH Clinical Center for Pre-Eclampsia

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: pre-eclampsia

Genetic Tests for Pre-Eclampsia

Genetic tests related to Pre-Eclampsia:

# Genetic test Affiliating Genes
1 Preeclampsia 29 NOS3

Anatomical Context for Pre-Eclampsia

MalaCards organs/tissues related to Pre-Eclampsia:

41
Placenta, Endothelial, Testes, Kidney, Liver, Heart, Lung

Publications for Pre-Eclampsia

Articles related to Pre-Eclampsia:

(show top 50) (show all 3336)
# Title Authors Year
1
Placental Elasticity as a New Non-invasive Predictive Marker of Pre-eclampsia. ( 30342781 )
2019
2
Maternal serum uric acid concentration and pregnancy outcomes in women with pre-eclampsia/eclampsia. ( 30353543 )
2019
3
Neutrophil-to-lymphocyte ratio and platelet indices in pre-eclampsia. ( 30362112 )
2019
4
Profound bilateral post-partum retinal circulation ischemia in two diabetic mothers with pre-eclampsia. ( 30519670 )
2019
5
Assessing the effect of dexmedetomidine in patients with pre-eclampsia. ( 30520788 )
2019
6
Nocturnal hypertension in high-risk mid-pregnancies predict the development of preeclampsia/eclampsia. ( 30015756 )
2019
7
Toll-like receptors signaling network in pre-eclampsia: An updated review. ( 30221394 )
2019
8
Helicobacter pylori infection and risk of preeclampsia: a systematic review and meta-analysis. ( 28889771 )
2019
9
Association of imbalanced sex hormone production with excessive procoagulation factor SerpinF2 in preeclampsia. ( 30020241 )
2019
10
MicroRNA-431 affects trophoblast migration and invasion by targeting ZEB1 in preeclampsia. ( 30315928 )
2019
11
Roles of microRNAs in preeclampsia. ( 30256424 )
2019
12
MicroRNAs in Preeclampsia. ( 30101723 )
2019
13
Excessive umbilical cord coiling confers risk of elevated nocturnal blood pressure and severe/early-onset preeclampsia. ( 30015757 )
2019
14
Do the physiological aging of the placenta and the changes in angiogenesis marker sFlt-1 and PlGF concentrations predispose patients to late-onset preeclampsia? ( 28816071 )
2019
15
Adverse maternal and neonatal outcomes in women with preeclampsia in Iran. ( 28871889 )
2019
16
Angiogenic factors for prediction of preeclampsia and intrauterine growth restriction onset in high-risk women: AngioPred study. ( 28889770 )
2019
17
Is it time to move towards non-invasive prenatal screening for Down syndrome and screening for pre-eclampsia? ( 29446241 )
2018
18
Hemoglobin levels during the first trimester of pregnancy are associated with the risk of gestational diabetes mellitus, pre-eclampsia and preterm birth in Chinese women: a retrospective study. ( 29940874 )
2018
19
The feasibility of task-sharing the identification, emergency treatment, and referral for women with pre-eclampsia by community health workers in India. ( 29945662 )
2018
20
Maternal cardiac output response to colloid preload and vasopressor therapy during spinal anaesthesia for caesarean section in patients with severe pre-eclampsia: a randomised, controlled trial. ( 29086911 )
2018
21
Induction of systemic inflammation by hyaluronan and hsp70 in women with pre-eclampsia. ( 29438905 )
2018
22
Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied in Portugal. ( 29367581 )
2018
23
Quality assessment of uterine artery Doppler measurement in first trimester combined screening for pre-eclampsia. ( 29917286 )
2018
24
Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta-analysis. ( 29978553 )
2018
25
Screening for pre-eclampsia at 35-37 weeks' gestation. ( 29896778 )
2018
26
Elabela-APJ axis contributes to embryonic development and prevents pre-eclampsia in pregnancy. ( 29342224 )
2018
27
Decidual regulation of trophoblast is altered in pregnancies at risk of pre-eclampsia. ( 29437882 )
2018
28
Measurement of area difference ratio of Photoplethysmographic pulse wave in patients with pre-eclampsia. ( 29970018 )
2018
29
Streptococcus pyogenes subdural empyema and pre-eclampsia. ( 29582773 )
2018
30
Associations between the timing and dosing of aspirin prophylaxis and term and preterm pre-eclampsia. ( 29880699 )
2018
31
Associations of polymorphisms of CYP2D6 and CYP2C9 with early onset severe pre-eclampsia and response to labetalol therapy. ( 29789925 )
2018
32
A case of partial hydatidiform molar pregnancy with a placental diploid-triploid mosaicism associated with a euploid viable foetus complicated with severe pre-eclampsia. ( 29421928 )
2018
33
Up-regulation of miR-299 suppressed the invasion and migration of HTR-8/SVneo trophoblast cells partly via targeting HDAC2 in pre-eclampsia. ( 29145147 )
2018
34
Three-dimensional indices of renal perfusion in normal pregnancy and pre-eclampsia. ( 29916133 )
2018
35
Combination of first trimester serum afamin levels and three-dimensional placental bed vascularization as a possible screening method to detect women at-risk for adverse pregnancy complications like pre-eclampsia and gestational diabetes mellitus in low-risk pregnancies. ( 29405972 )
2018
36
Study on the correlation between adipocyte fatty-acid binding protein, glucolipid metabolism, and pre-eclampsia. ( 29316087 )
2018
37
Utility of serology in the diagnosis of pre-eclampsia and haemolytic uraemic syndrome in pregnancy-related acute kidney injury. ( 29890047 )
2018
38
Screening for pre-eclampsia by maternal factors and biomarkers at 11-13a88weeks' gestation. ( 29896812 )
2018
39
Re: Placental histopathology associated with pre-eclampsia: a systematic review and meta-analysis. ( 29417682 )
2018
40
Prediction and prevention of pre-eclampsia in Asian subpopulation. ( 29442407 )
2018
41
HLA-DR is aberrantly expressed at feto-maternal interface in pre-eclampsia. ( 29941324 )
2018
42
Are women with history of pre-eclampsia starting a new pregnancy in good nutritional status in South Africa and Zimbabwe? ( 29907146 )
2018
43
Baseline check of blood pressure readings of an automated device in severe pre-eclampsia and healthy normotensive pregnancy. ( 29674198 )
2018
44
Association between fetal fraction on cell-free DNA testing and first trimester markers for pre-eclampsia. ( 29318732 )
2018
45
Effect of blood pressure on reversible posterior leukoencephalopathy syndrome in pre-eclampsia or eclampsia. ( 29093565 )
2018
46
Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models. ( 29970026 )
2018
47
Pre-eclampsia and the risk of autism-spectrum disorder in offspring: meta-analysis. ( 29436313 )
2018
48
Dexmedetomidine as a part of general anaesthesia for caesarean delivery in patients with pre-eclampsia: Efficacy and foetal outcome: a randomised double-blinded trial. ( 29432379 )
2018
49
The potential therapeutic effects of ergothioneine in pre-eclampsia. ( 29284116 )
2018
50
Int6/eIF3e Silencing Promotes Placenta Angiogenesis in a Rat Model of Pre-eclampsia. ( 29895936 )
2018